Small cell lung cancer
Conditions
Interventions
Small cell lung cancer:chemotherapy regimens Lobaplatin-contained
Sponsors
Jilin Province Tumor Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. Not less than 18 years old, male or female patients; 2. With the diagnosis of Small cell lung cancer confirmed by pathological or cytology tests; 3. Without limiting the phase and the once treatment; 4. With measurable tumor foci; 5. ECOG PS0-2; 6. Life expectancy >=3 months; 7. Laboratory parameters: Bone marrow function: ANC>=1.5×10^9/L; PLT>=100×10^9/L; HB>=90g/L; Hepatic function: STB and CB=60 ml/min (Cockcroft-Gault); 8. Keep contraception during the administration and 6 months later;not breastfeeding; 9. Voluntary to participate and sign informed consent document.
Exclusion criteria
Exclusion criteria: 1. Allergic to platinum drugs used in the trial; 2. The patients with coagulation dysfunction; 3. Other patients that are not suitable for inclusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the Safety; | — |
Secondary
| Measure | Time frame |
|---|---|
| the effectivenes; | — |
Countries
China
Contacts
Public ContactYing Cheng
Outcome results
None listed